Cargando…
Use of the SMAS flap for reconstruction of the parotid lodge
The purpose of our study was to evaluate the benefits of the SMAS flap in patients with benign tumours of the parotid gland treated by superficial parotidectomy. We carried out a retrospective chart review on 123 patients suffering from benign tumours of the parotid gland admitted to our Institution...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SRL
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755052/ https://www.ncbi.nlm.nih.gov/pubmed/26900246 http://dx.doi.org/10.14639/0392-100X-395 |
_version_ | 1782416135295074304 |
---|---|
author | DELL'AVERSANA ORABONA, G. SALZANO, G. ABBATE, V. PIOMBINO, P. ASTARITA, F. IACONETTA, G. CALIFANO, L. |
author_facet | DELL'AVERSANA ORABONA, G. SALZANO, G. ABBATE, V. PIOMBINO, P. ASTARITA, F. IACONETTA, G. CALIFANO, L. |
author_sort | DELL'AVERSANA ORABONA, G. |
collection | PubMed |
description | The purpose of our study was to evaluate the benefits of the SMAS flap in patients with benign tumours of the parotid gland treated by superficial parotidectomy. We carried out a retrospective chart review on 123 patients suffering from benign tumours of the parotid gland admitted to our Institution between March 1997 and March 2010. A superficial parotidectomy was performed in all the cases reported. Our sample was divided in two groups basing SMAS flap reconstruction done (Group 2) or not (Group 1) after superficial parotidectomy. Reconstruction using SMAS flap was accomplished in 64 patients. Chi-square test was used to assess statistical difference between the two groups. The level of statistical significance was P < 0.05. No significant differences concerning hematoma, wound infection and facial paralysis were observed between the first and second group (3.38 vs 1.56% [P > 0.05], 8.47% vs 4.68% [P > 0.05], 5.08% vs 0.00% [P > 0.05]). Transient facial nerve weakness, fistula, dip skin and Frey's syndrome were significantly more frequent without SMAS flap reconstruction (10.16% vs 3.125% [P < 0.05], 13.55% vs 3.125% [P < 0.05], 13.55% vs 3.125% [P < 0.05], 20.33% vs 0% [P < 0.05] respectively). The use of the SMAS flap is able to reduce the cosmetic and functional complications that occur after the removal of a benign tumour of the parotid through the superficial parotidectomy technique, above all, it reduces the occurrence of Frey's syndrome. |
format | Online Article Text |
id | pubmed-4755052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Pacini Editore SRL |
record_format | MEDLINE/PubMed |
spelling | pubmed-47550522016-02-19 Use of the SMAS flap for reconstruction of the parotid lodge DELL'AVERSANA ORABONA, G. SALZANO, G. ABBATE, V. PIOMBINO, P. ASTARITA, F. IACONETTA, G. CALIFANO, L. Acta Otorhinolaryngol Ital Salivary Glands The purpose of our study was to evaluate the benefits of the SMAS flap in patients with benign tumours of the parotid gland treated by superficial parotidectomy. We carried out a retrospective chart review on 123 patients suffering from benign tumours of the parotid gland admitted to our Institution between March 1997 and March 2010. A superficial parotidectomy was performed in all the cases reported. Our sample was divided in two groups basing SMAS flap reconstruction done (Group 2) or not (Group 1) after superficial parotidectomy. Reconstruction using SMAS flap was accomplished in 64 patients. Chi-square test was used to assess statistical difference between the two groups. The level of statistical significance was P < 0.05. No significant differences concerning hematoma, wound infection and facial paralysis were observed between the first and second group (3.38 vs 1.56% [P > 0.05], 8.47% vs 4.68% [P > 0.05], 5.08% vs 0.00% [P > 0.05]). Transient facial nerve weakness, fistula, dip skin and Frey's syndrome were significantly more frequent without SMAS flap reconstruction (10.16% vs 3.125% [P < 0.05], 13.55% vs 3.125% [P < 0.05], 13.55% vs 3.125% [P < 0.05], 20.33% vs 0% [P < 0.05] respectively). The use of the SMAS flap is able to reduce the cosmetic and functional complications that occur after the removal of a benign tumour of the parotid through the superficial parotidectomy technique, above all, it reduces the occurrence of Frey's syndrome. Pacini Editore SRL 2015-12 /pmc/articles/PMC4755052/ /pubmed/26900246 http://dx.doi.org/10.14639/0392-100X-395 Text en © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to http://creativecommons.org/licenses/by-nc-nd/3.0/ |
spellingShingle | Salivary Glands DELL'AVERSANA ORABONA, G. SALZANO, G. ABBATE, V. PIOMBINO, P. ASTARITA, F. IACONETTA, G. CALIFANO, L. Use of the SMAS flap for reconstruction of the parotid lodge |
title | Use of the SMAS flap for reconstruction of the parotid lodge |
title_full | Use of the SMAS flap for reconstruction of the parotid lodge |
title_fullStr | Use of the SMAS flap for reconstruction of the parotid lodge |
title_full_unstemmed | Use of the SMAS flap for reconstruction of the parotid lodge |
title_short | Use of the SMAS flap for reconstruction of the parotid lodge |
title_sort | use of the smas flap for reconstruction of the parotid lodge |
topic | Salivary Glands |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755052/ https://www.ncbi.nlm.nih.gov/pubmed/26900246 http://dx.doi.org/10.14639/0392-100X-395 |
work_keys_str_mv | AT dellaversanaorabonag useofthesmasflapforreconstructionoftheparotidlodge AT salzanog useofthesmasflapforreconstructionoftheparotidlodge AT abbatev useofthesmasflapforreconstructionoftheparotidlodge AT piombinop useofthesmasflapforreconstructionoftheparotidlodge AT astaritaf useofthesmasflapforreconstructionoftheparotidlodge AT iaconettag useofthesmasflapforreconstructionoftheparotidlodge AT califanol useofthesmasflapforreconstructionoftheparotidlodge |